“melanoma” Archives

Entry Author Date Location
Big Deals in Texas (ZS Pharma, HomeAway, Gravitant) & Other News 11/09/15 Texas
DermTech Looks to Build on Alternative Test for Skin Cancer 11/05/15 San Diego
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
Houston’s Fannin Forms Company to Fight Inflammation-Induced Cancers 09/21/15 Texas
In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer 08/31/15 New York
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try 08/24/15 Boston
West Coast Biotech Roundup: Kythera, Amgen, Otonomy, Versant & More 04/30/15 San Diego
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
Array Biopharma Gets Rights to Second Novartis Cancer Drug 01/23/15 Boulder/Denver
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
Pioneer’s Lament: Lack of Checkpoint Immunotherapy For Blood Cancer 12/08/14 National
Array and Novartis End Development Deal for Cancer Drug Binimetinib 12/04/14 Boulder/Denver
Texas Cancer Center Seeks to Speed Discovery with Applied Research 12/03/14 Texas
MD Anderson Showcases “Moon Shots” Progress in Fight Against Cancer 11/03/14 Texas
Texas Roundup: New funds for Castle, Quarri, Omni Water, & Pivot3 08/14/14 Texas
Houston Cancer Diagnostics Firm Castle Biosciences Raises $11.8M 08/13/14 Texas
West Coast Biotech Roundup: Genentech, CareDx, and More 07/17/14 San Diego
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
East Coast Biotech Roundup: VentriNova, RainDance, Biogen, & More 03/07/14 Boston
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
DermTech Raises $5.6M to Develop New Test for Deadliest Skin Cancer 08/21/13 San Diego
Array Starts First Phase 3 Trial, Shifts to Late-Stage Development 07/03/13 Boulder/Denver
Merck Joins Bristol, Genentech in Great Cancer Immunotherapy Race 06/02/13 New York
Ziopharm Awaits Cancer Drug Data as Wall Street Withholds Judgment 08/29/12 New York
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer 05/24/11 Seattle
Genentech Gears Up for ASCO, Pushing Data on Personalized Cancer Medicine 05/18/11 San Francisco
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News 04/28/11 San Diego
Page 1 of 2 next page »